Tonys show 11-5-2020

Tonys show 11-5-2020

augmentinforce.com alternative to the alternatives             

 DIY health and protection against Freq https://www.bitchute.com/channel/gS5E0SSRIbLH/

 Vids on Alternatives to the alternatives  https://www.youtube.com/user/HerbsPlusBeadWorks/videos?view_as=subscriber

Consultation link  https://blog.iyannis.com/consultation-with-tony-pantalleresco/  

ANTHONYPANTALLERESCO       https://purebulk.com?sca_ref=255774.CQCu0SoeKR  discount code for Pure bulk

If customers make purchase via this affiliate link, the discount code ANTHONYPANTALLERESCO will be automatically applied.

 Bryan 396 nano Photo gallery  https://photos.google.com/share/AF1QipNGjvv80IymebVS0H-h9Jo5qguc1MsQixcVPJQk_I_YmxrPgqXbrqxOCvTTTDrduA?key=NjQxY2p6dlZmR0F2MTlfR2dqSUlZd3ExdkpwS3h3%5C

 Bryan 396 Data and research on nanobiotech  https://www.minds.com/Bryan396/blogs

Bryan 396 nano tech researcher Patreon https://www.patreon.com/posts/tonys-message-34355614

 Aroy Maks Channel and information on health and current events https://www.youtube.com/watch?v=Y01JEb98s1o and  https://www.hooktube.com/watch?v=Y01JEb98s1o

Yannis interview with shaui  https://www.youtube.com/watch?v=LgmUFXOpbVA&feature=youtu.be

https://blog.iyannis.com/  blog by aroy mak

The bermuda "Triangle" --Yannis Tutorial https://www.youtube.com/watch?v=MFITP924Rj4&feature=youtu.be

Three Heart Church Freq and Nano-- https://www.youtube.com/watch?v=jXCOYWGA1zs   or   https://hooktube.com/watch?v=jXCOYWGA1zs

InterView with Ty @ Enerchi wellness https://enerchiwellness.podbean.com

Nanoparticles Hazards are Measured http://m.uploadedit.com/busd/1604547949591.pdf

Globization through mind control and New Age http://m.uploadedit.com/busd/1604545661115.pdf

Rolling lockdowns in canada  https://www.youtube.com/watch?v=21Sx4oxg4tQ&feature=youtu.be

Hawthorn Leaf and Flower

Research has been conducted on various hawthorn preparations, with the majority using a proprietary preparation from the leaf and flowers (L1 132; WS 1442). Other preparations include leaf and flower combinations with and without the berries, aqueous extracts, methanolic extracts (L1 132; Faros), ethanolic extracts (Esbericard, Crataegutt), dried blossoms, and a flavonoid extract (Crataemon).

The exact mechanisms of action for hawthorn and cardiovascular disease is uncertain, but it is thought that the primary activity is its ability to increase coronary arterial blood flow, perhaps due to dilation of the coronary arteries. The inotropic effects may be due to inhibition of myocardial sodium/potassium ATPase. Hawthorn also appears to slightly increase the strength of the cardiac muscle contractions and decrease blood pressure, resulting in increased exercise tolerance and protection against congestive heart failure. Hawthorn has also been shown to exhibit antioxidant activity in a number of studies, which is likely due to its flavonoid and procyanidin constituents.4,5,6

Numerous randomized, placebo-controlled clinical trials report hawthorn’s ability to improve exercise capacity, alleviate symptoms of cardiac insufficiency, and treat mild to moderate congestive heart failure (CHF), the area of the most research.

The largest, recent, and well-known study, The Survival and Prognosis: Investigation of Crataegus Extract WS 1442 in Congestive Heart Failure (SPICE) trial, was designed to assess the safety of a standardized hawthorn extract, WS 1442, and its effects on morbidity and mortality in patients with New York Heart Association (NYHA) class II and III CHF; hawthorn was used in addition to optimal standard care.7 The randomized, multicenter, double-blind, placebo-controlled study enrolled 2,681 patients and was performed at 156 centers in 13 European countries. Patients with NYHA class II and III CHF and reduced left ventricular function ≤35%) were randomized to either the study medication (450 mg WS 1442 twice daily) or placebo in addition to conventional treatment for 24 months.

WS 1442 had no impact on the primary endpoint (composite endpoint of cardiac mortality, nonfatal myocardial infarction, and hospitalization due to progression of heart failure), with a rate of 27.9% in the treatment group vs 28.9% in the placebo group. In addition, after 24 months there was no difference in the rates of cardiac mortality or sudden cardiac death between the 2 groups. However, in a subgroup analysis of patients with a left ventricular ejection fraction (LVEF) ≥25%, sudden cardiac death was significantly lower in the WS 1442 group. These particular findings highlight the potential anti-arrhythmic and/or anti-ischemic mechanisms of hawthorn extract. Although add-on treatment with WS 1442 did not show a significant difference in cardiac death, non-fatal myocardial infarction, or hospitalization due to significant heart failure, it did reduce sudden cardiac death, which is more prominent in patients with LVEF between 25% and 35% (the upper limit for inclusion in the study). The SPICE trial was more rigorous in its primary endpoints related to heart failure when compared to the other studies below, which looked more at symptoms of dyspnea, fatigue, and cardiac performance. The SPICE trial demonstrates to clinicians that perhaps we cannot reduce the sudden death and myocardial infarctions associated with CHF unless the patient has a less compromised left ventricular function. While its effect on morbidity and mortality is not conclusive, strong evidence suggests symptoms and quality of life related to CHF may be improved with the use of hawthorn extracts.

A meta-analysis of studies using hawthorn for chronic cardiac failure provided evidence of its efficacy in chronic heart failure.8 This systematic review of controlled trials revealed that hawthorn extract was significantly more beneficial than placebo for maximal workload. Symptoms of dyspnea and fatigue also decreased significantly with hawthorn compared with placebo.

In 1996, a systematic review was done of 7 controlled trials that met the NYHA class I or II heart failure criteria.9 These studies demonstrated clinical improvement with hawthorn extract with decreases in symptoms and objective evidence of efficacy most often proven by exercise ergometry.

Additional randomized studies have also been positive. In a 1974 study, 10 mg hawthorn berry and 30 mg hawthorn leaf was added to a nitrate.10 In 25% of the patients with severe coronary sclerosis and congestive heart failure, the combination of drug treatment and hawthorn was superior to drug treatment alone. A 1984 trial using 360–1,600 mg/day of hawthorn extract demonstrated improvement in overall cardiac performance in the treatment group (77%) vs placebo (49%).

How to make a Hawthorn Solution with cq10

get 1/4 cup of laf and flower local health shop or online ---add to blende and add 1.5 cup of ethanol( any drinking alcohol ---brandy would be a good choice here ) and put in blender and blend for 10 minutes

--when done with blending turn of blender and proceed to filter the solution with a handkerchief

then proceed once filtered to add the clean solution to either a hot plate container or a pot or then  proceed to simmer down the solution ---as it begins add either 1-2 grams of cq 10 powder or open up the equivalent fom capsules and then proceed to simmer it down til it gets to a stage or where it begins to thicken as an oil---now in a hot plate utilize a spinner ---if you do not have one then use a slow cooker and cook it down to about 1/2 inch from bottom

bottle it and store and use --label it hawthorn and cq10--use 1/10 of a tsp straight several times a day or add to any beverage --brandy -cognac- vodka -rum - coffee and any form of teas

Town of Aylmer Sunday Nov 7th 1:30--Protest  to the mask and rolling shutdowns

see  wimkin.com /independz for more details